In the past five years, the university has been awarded $6.2 million in eye research funding from various sources. Researchers include Douglas R. Lazzaro, MD, professor and chair of ophthalmology; William J. Brunken, PhD, professor of cell biology and ophthalmology and director of ophthalmic research; and John Danias, MD, PhD, professor of cell biology and ophthalmology. The team will research the role of the extracellular matrix in retinal development and disease and new treatment options for glaucoma.
Related Articles on Ophthalmology:
FDA Approves Carl Zeiss Meditec’s Cirrus HD-OCT for Dry AMD and Glaucoma
Dr. Paul Lee Appointed Director of the W.K. Kellogg Eye Center at University of Michigan
Florida Eye Institute to Offer New and Expanded Range of Lens Implants for Cataract Patients
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.